Essity Continues the Optimization of its Production in the United States
STOCKHOLM, Sept. 18, 2018 /PRNewswire/ --
To further increase the efficiency of the Professional Hygiene business, Essity is closing its converting facility in Bellemont, Arizona, United States.
The closure will be completed in the second half of 2019 without any disruption to customers. Production will be reallocated to other Essity production facilities in the United States. The measures are aligned with the company's strategy to optimize the production footprint to improve cost and capital efficiency and further increase value creation in the Professional Hygiene business area.
The restructuring costs are expected to amount to approximately SEK 150m which is expected to be recognized as an item affecting comparability in the third quarter of 2018. Approximately SEK 30m of the restructuring costs are expected to impact cash flow.
For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46-8-788-52-51, [email protected] Johan Karlsson, Vice President Investor Relations, +46-8-788-51-30, [email protected]
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...